These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 25186603
1. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Katsara M, Deraos S, Tselios TV, Pietersz G, Matsoukas J, Apostolopoulos V. Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603 [Abstract] [Full Text] [Related]
2. Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice. Katsara M, Yuriev E, Ramsland PA, Tselios T, Deraos G, Lourbopoulos A, Grigoriadis N, Matsoukas J, Apostolopoulos V. Immunology; 2009 Dec; 128(4):521-33. PubMed ID: 19930042 [Abstract] [Full Text] [Related]
3. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice. Katsara M, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V. J Med Chem; 2008 Jul 10; 51(13):3971-8. PubMed ID: 18563891 [Abstract] [Full Text] [Related]
4. Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis. Katsara M, Deraos G, Tselios T, Matsoukas MT, Friligou I, Matsoukas J, Apostolopoulos V. J Med Chem; 2009 Jan 08; 52(1):214-8. PubMed ID: 19072222 [Abstract] [Full Text] [Related]
5. Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis. Lourbopoulos A, Matsoukas MT, Katsara M, Deraos G, Giannakopoulou A, Lagoudaki R, Grigoriadis N, Matsoukas J, Apostolopoulos V. Bioorg Med Chem; 2018 May 15; 26(9):2221-2228. PubMed ID: 29681483 [Abstract] [Full Text] [Related]
6. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ, Kennedy KJ, Smith WS, Miller SD. J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901 [Abstract] [Full Text] [Related]
7. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. Carrizosa AM, Nicholson LB, Farzan M, Southwood S, Sette A, Sobel RA, Kuchroo VK. J Immunol; 1998 Oct 01; 161(7):3307-14. PubMed ID: 9759846 [Abstract] [Full Text] [Related]
8. Cyclic citrullinated MBP87-99 peptide stimulates T cell responses: Implications in triggering disease. Apostolopoulos V, Deraos G, Matsoukas MT, Day S, Stojanovska L, Tselios T, Androutsou ME, Matsoukas J. Bioorg Med Chem; 2017 Jan 15; 25(2):528-538. PubMed ID: 27908754 [Abstract] [Full Text] [Related]
9. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H. J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788 [Abstract] [Full Text] [Related]
10. A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses. Katsara M, Yuriev E, Ramsland PA, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V. J Neuroimmunol; 2008 Aug 30; 200(1-2):77-89. PubMed ID: 18675465 [Abstract] [Full Text] [Related]
11. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. Whitham RH, Jones RE, Hashim GA, Hoy CM, Wang RY, Vandenbark AA, Offner H. J Immunol; 1991 Dec 01; 147(11):3803-8. PubMed ID: 1719089 [Abstract] [Full Text] [Related]
12. Male SJL mice do not relapse after induction of EAE with PLP 139-151. Bebo BF, Vandenbark AA, Offner H. J Neurosci Res; 1996 Sep 15; 45(6):680-9. PubMed ID: 8892079 [Abstract] [Full Text] [Related]
13. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor. Kobayashi N, Kobayashi H, Gu L, Malefyt T, Siahaan TJ. J Pharmacol Exp Ther; 2007 Aug 15; 322(2):879-86. PubMed ID: 17522343 [Abstract] [Full Text] [Related]
14. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis. Deraos G, Rodi M, Kalbacher H, Chatzantoni K, Karagiannis F, Synodinos L, Plotas P, Papalois A, Dimisianos N, Papathanasopoulos P, Gatos D, Tselios T, Apostolopoulos V, Mouzaki A, Matsoukas J. Eur J Med Chem; 2015 Aug 28; 101():13-23. PubMed ID: 26112377 [Abstract] [Full Text] [Related]
15. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. Ford ML, Evavold BD. Eur J Immunol; 2004 Feb 28; 34(2):388-97. PubMed ID: 14768043 [Abstract] [Full Text] [Related]
16. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD. J Immunol; 1998 May 01; 160(9):4271-9. PubMed ID: 9574529 [Abstract] [Full Text] [Related]
17. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809 [Abstract] [Full Text] [Related]
18. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. Falk K, Rötzschke O, Santambrogio L, Dorf ME, Brosnan C, Strominger JL. J Exp Med; 2000 Feb 21; 191(4):717-30. PubMed ID: 10684863 [Abstract] [Full Text] [Related]
19. Functional activation of myelin-specific T cells by virus-induced molecular mimicry. Olson JK, Eagar TN, Miller SD. J Immunol; 2002 Sep 01; 169(5):2719-26. PubMed ID: 12193746 [Abstract] [Full Text] [Related]
20. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K, Chandler P, Altmann DM. Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]